Biotech Company Develops Inebriation Remedy Beverage ‘UNBUZZD’
HUGE Biopharma Australia, a subsidiary of biopharma company FSD Pharma Inc. (NASDAQ:HUGE), has agreed with clinical research organization Ingenu CRO to conduct a cross-over clinical study on a proprietary licensed beverage targeting alcohol metabolization in intoxicated states.
Made up of natural ingredients, vitamins and minerals, UNBUZZD is believed to help with liver and brain function to quickly relieve individuals from the effects of alcohol consumption.
The randomized, double-blind, placebo-controlled trial (METAL-1 TRIAL) will assess the safety and efficacy of unbuzzd in healthy volunteers in an induced state of alcohol intoxication, an important step “to further verify that the effects of drinking unbuzzd helps a person sober up faster from the …